Regulatory Authorities and Reimbursement Mechanisms
This chapter looks at the role of regulators and reimbursement systems in facilitating the uptake of pharmacogenetics by health‐care systems. Regulators and coverage policies will be strong factors in the rate of diffusion of pharmacogenetics. Reimbursement policies and cost‐containment strategies for drug and test‐use policies and clinical guidelines will be very important. The challenges for payers and the trade‐offs they may have to make are also considered.
No Supplementary Data
Document Type: Review Article
Publication date: 2009-11-01